Italy research chief
Physicist Massimo Inguscio took office on 22 February as president of Italy's National Research Council (CNR). Inguscio, who comes to the post from the University of Florence, will need to ensure that research in the 103 CNR institutes can stay on track without significant institutional funds -salaries and general expenses absorb most of the CNR's budget. He will also need to maintain the organization's
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Earthquake action
Citing a sharp spike in earthquake activity, a US environmental group has filed a federal lawsuit seeking to curb the injection of wastewater from hydraulic fracturing (fracking) and oil activities in Oklahoma. The California-based Sierra Club, working with law firm Public Justice, filed the lawsuit against 3 energy companies on 16 February, 3 days after a magnitude-5.1 earthquake shook the state. There were 907 earthquakes of magnitude 3 or larger in 2015, compared with 109 in 2013. Scientists have linked the earthquakes to the injection of wastewater, a by-product of fracking.
FDA vote due
As Nature went to press, the US Senate was poised to vote on the nominee to head the US Food and Drug Administration (FDA), clinical-trials expert Robert Califf. On 22 February, lawmakers voted to limit debate on Califf 's nomination, setting the stage for a final vote that will determine whether he will become FDA commissioner. President Barack Obama nominated Califf last September, but some lawmakers delayed
ExxonMobil anger
More than 100 scientists have signed a letter urging the American Geophysical Union (AGU) to reject sponsorship from US oil and gas giant ExxonMobil. Following news reports in late 2015 that indicated that ExxonMobil scientists knew about the threat of global warming decades ago, the letter says that ExxonMobil's complicity in spreading "climate denial and misinformation" has been well documented. "By allowing Exxon to appropriate AGU's institutional social license to help legitimize the company's climate misinformation, AGU is undermining its stated values as well as the work of many of its own members, " the 22 February letter states.
The European Space Agency successfully launched the Earth-observing satellite Sentinel-3A on 16 February. The launch, from Plesetsk, Russia, carried a suite of four Earth-observing instruments into orbit as part of Europe's Copernicus programme. Sentinel-3A is one of two identical satellites, the second of which will launch in 2017. Over the oceans, they will measure sea surface temperatures and sea-ice thickness, and over land they will map how land is used, the extent of vegetation and the height of rivers and lakes. Two other Sentinel satellites launched in 2014 and 2015.
Sentinel-3A launches to monitor Earth 
January heats up
Last month was the world's hottest January since records began in 1880, and the ninth month in a row to break a global monthly temperature record, the US National Oceanic and Atmospheric 
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Stem-cell leader
Stem-cell biologist Robert Lanza announced on 22 February that he will be the head of global regenerative medicine for Astellas Pharma, the Tokyo-based firm that acquired Lanza's company Ocata Therapeutics earlier this month. Lanza is the chief scientific officer for Ocata, based in Marlborough, Massachusetts, which has been a leader in developing stemcell therapies, despite financial troubles and management changes over the past 15 years (see Nature 481, 130-133; its wide-range view, it will be able to measure light from one billion galaxies and illuminate the nature of the dark energy thought to be accelerating the expansion of the Universe.
